 |
Previous Article | Next Article 
The Journal of Neuroscience, October 1, 2001, 21(19):7463-7473
The Brain Metabolite Kynurenic Acid Inhibits 7 Nicotinic
Receptor Activity and Increases Non- 7 Nicotinic Receptor Expression:
Physiopathological Implications
Corey
Hilmas1,
Edna F. R.
Pereira1,
Manickavasagom
Alkondon1,
Arash
Rassoulpour2,
Robert
Schwarcz1, 2, and
Edson X.
Albuquerque1, 3
1 Department of Pharmacology and Experimental
Therapeutics and 2 Maryland Psychiatric Research Center,
University of Maryland School of Medicine, Baltimore, Maryland 21201, and 3 Departamento de Farmacologia Básica e
Clínica, Instituto de Ciências Biomédicas, Centro
de Ciências da Saúde, Universidade Federal do Rio de
Janeiro, Rio de Janeiro, RJ 21944, Brazil
The tryptophan metabolite kynurenic acid (KYNA) has long been
recognized as an NMDA receptor antagonist. Here, interactions between
KYNA and the nicotinic system in the brain were investigated using the
patch-clamp technique and HPLC. In the electrophysiological studies, agonists were delivered via a U-shaped tube, and KYNA was
applied in admixture with agonists and via the background perfusion.
Exposure ( 4 min) of cultured hippocampal neurons to KYNA ( 100
nM) inhibited activation of somatodendritic 7 nAChRs; the IC50 for KYNA was ~7 µM. The inhibition
of 7 nAChRs was noncompetitive with respect to the agonist and
voltage independent. The slow onset of this effect could not be
accounted for by an intracellular action because KYNA (1 mM) in the pipette solution had no effect on 7 nAChR
activity. KYNA also blocked the activity of preterminal/presynaptic 7 nAChRs in hippocampal neurons in cultures and in slices. NMDA receptors were less sensitive than 7 nAChRs to KYNA. The
IC50 values for KYNA-induced blockade of NMDA receptors in
the absence and presence of glycine (10 µM) were ~15
and 235 µM, respectively. Prolonged (3 d) exposure of
cultured hippocampal neurons to KYNA increased their nicotinic
sensitivity, apparently by enhancing 4 2 nAChR expression.
Furthermore, as determined by HPLC with fluorescence detection,
repeated systemic treatment of rats with nicotine caused a transient
reduction followed by an increase in brain KYNA levels. These results
demonstrate that nAChRs are targets for KYNA and suggest a functionally
significant cross talk between the nicotinic cholinergic system and the
kynurenine pathway in the brain.
Key words:
nicotinic ACh receptors; NMDA receptors; hippocampus; kynurenic acid; electrophysiology; brain slices
Copyright © 2001 Society for Neuroscience 0270-6474/01/21197463-11$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
M. C. Barth, N. Ahluwalia, T. J. T. Anderson, G. J. Hardy, S. Sinha, J. A. Alvarez-Cardona, I. E. Pruitt, E. P. Rhee, R. A. Colvin, and R. E. Gerszten
Kynurenic Acid Triggers Firm Arrest of Leukocytes to Vascular Endothelium under Flow Conditions
J. Biol. Chem.,
July 17, 2009;
284(29):
19189 - 19195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Han, H. Robinson, T. Cai, D. A. Tagle, and J. Li
Biochemical and Structural Properties of Mouse Kynurenine Aminotransferase III
Mol. Cell. Biol.,
February 1, 2009;
29(3):
784 - 793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. X. Albuquerque, E. F. R. Pereira, M. Alkondon, and S. W. Rogers
Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function
Physiol Rev,
January 1, 2009;
89(1):
73 - 120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pignatelli and O. Belluzzi
Cholinergic Modulation of Dopaminergic Neurons in the Mouse Olfactory Bulb
Chem Senses,
April 1, 2008;
33(4):
331 - 338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Rossi, S. Garavaglia, V. Montalbano, M. A. Walsh, and M. Rizzi
Crystal Structure of Human Kynurenine Aminotransferase II, a Drug Target for the Treatment of Schizophrenia
J. Biol. Chem.,
February 8, 2008;
283(6):
3559 - 3566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Han, H. Robinson, and J. Li
Crystal Structure of Human Kynurenine Aminotransferase II
J. Biol. Chem.,
February 8, 2008;
283(6):
3567 - 3573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Guo, D. J. Williams, H. L. Puhl III, and S. R. Ikeda
Inhibition of N-Type Calcium Channels by Activation of GPR35, an Orphan Receptor, Heterologously Expressed in Rat Sympathetic Neurons
J. Pharmacol. Exp. Ther.,
January 1, 2008;
324(1):
342 - 351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Goddard, E. I. Knudsen, and J. R. Huguenard
Intrinsic Excitability of Cholinergic Neurons in the Rat Parabigeminal Nucleus
J Neurophysiol,
December 1, 2007;
98(6):
3486 - 3493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Guillemin, K. M. Cullen, C. K. Lim, G. A. Smythe, B. Garner, V. Kapoor, O. Takikawa, and B. J. Brew
Characterization of the Kynurenine Pathway in Human Neurons
J. Neurosci.,
November 21, 2007;
27(47):
12884 - 12892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-B. You, B. Wang, D. Zitzman, S. Azari, and R. A. Wise
A Role for Conditioned Ventral Tegmental Glutamate Release in Cocaine Seeking
J. Neurosci.,
September 26, 2007;
27(39):
10546 - 10555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. N. Browning and R. A. Travagli
Functional Organization of Presynaptic Metabotropic Glutamate Receptors in Vagal Brainstem Circuits
J. Neurosci.,
August 22, 2007;
27(34):
8979 - 8988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lopes, E. F. R. Pereira, H.-Q. Wu, P. Purushottamachar, V. Njar, R. Schwarcz, and E. X. Albuquerque
Competitive Antagonism between the Nicotinic Allosteric Potentiating Ligand Galantamine and Kynurenic Acid at {alpha}7* Nicotinic Receptors
J. Pharmacol. Exp. Ther.,
July 1, 2007;
322(1):
48 - 58.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Chess, M. K. Simoni, T. E. Alling, and D. J. Bucci
Elevations of Endogenous Kynurenic Acid Produce Spatial Working Memory Deficits
Schizophr Bull,
May 1, 2007;
33(3):
797 - 804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Alkondon, E. F. R. Pereira, M. C. Potter, F. C. Kauffman, R. Schwarcz, and E. X. Albuquerque
Strain-Specific Nicotinic Modulation of Glutamatergic Transmission in the CA1 Field of the Rat Hippocampus: August Copenhagen Irish Versus Sprague-Dawley
J Neurophysiol,
February 1, 2007;
97(2):
1163 - 1170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Rossi, Q. Han, J. Li, J. Li, and M. Rizzi
Crystal Structure of Human Kynurenine Aminotransferase I
J. Biol. Chem.,
November 26, 2004;
279(48):
50214 - 50220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Yu, N. A. Di Prospero, M. T. Sapko, T. Cai, A. Chen, M. Melendez-Ferro, F. Du, W. O. Whetsell Jr., P. Guidetti, R. Schwarcz, et al.
Biochemical and Phenotypic Abnormalities in Kynurenine Aminotransferase II-Deficient Mice
Mol. Cell. Biol.,
August 15, 2004;
24(16):
6919 - 6930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. L. Hanganu and H. J. Luhmann
Functional Nicotinic Acetylcholine Receptors on Subplate Neurons in Neonatal Rat Somatosensory Cortex
J Neurophysiol,
July 1, 2004;
92(1):
189 - 198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Alkondon, E. F. R. Pereira, P. Yu, E. Z. Arruda, L. E. F. Almeida, P. Guidetti, W. P. Fawcett, M. T. Sapko, W. R. Randall, R. Schwarcz, et al.
Targeted Deletion of the Kynurenine Aminotransferase II Gene Reveals a Critical Role of Endogenous Kynurenic Acid in the Regulation of Synaptic Transmission via {alpha}7 Nicotinic Receptors in the Hippocampus
J. Neurosci.,
May 12, 2004;
24(19):
4635 - 4648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Zhao, Y.-P. Kuo, A. A. George, J.-H. Peng, M. S. Purandare, K. M. Schroeder, R. J. Lukas, and J. Wu
Functional Properties of Homomeric, Human {alpha}7-Nicotinic Acetylcholine Receptors Heterologously Expressed in the SH-EP1 Human Epithelial Cell Line
J. Pharmacol. Exp. Ther.,
June 1, 2003;
305(3):
1132 - 1141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Csillik, E. Okuno, B. Csillik, E. Knyihar, and L. Vecsei
Expression of Kynurenine Aminotransferase in the Subplate of the Rat and Its Possible Role in the Regulation of Programmed Cell Death
Cereb Cortex,
November 1, 2002;
12(11):
1193 - 1201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Schwarcz and R. Pellicciari
Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities
J. Pharmacol. Exp. Ther.,
October 1, 2002;
303(1):
1 - 10.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. J. Kwok, R. Kapoor, T. Gotoda, Y. Iwamoto, Y. Iizuka, N. Yamada, K. E. Isaacs, V. V. Kushwaha, W. B. Church, P. R. Schofield, et al.
A Missense Mutation in Kynurenine Aminotransferase-1 in Spontaneously Hypertensive Rats
J. Biol. Chem.,
September 20, 2002;
277(39):
35779 - 35782.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|